Celldex Therapeutics Inc (NASDAQ:CLDX)
| 18.70 Delayed Data As of 4:00pm ET |  +0.90 / +5.06%Today’s Change | 1.50 Today|||52-Week Range 23.40 | +6.74% Year-to-Date |
Latest CLDX News | Press Releases
No recent news for Celldex Therapeutics Inc.
Today’s Trading
| Previous close | 17.80 |
| Today’s open | 18.05 |
| Day’s range | 17.65 - 18.83 |
| Volume | 16,890 |
| Average volume (3 months) | 701,831 |
| Market cap | $703.9M |
Data as of 4:00pm ET, 01/25/2021
Growth & Valuation
| Earnings growth (last year) | +75.78% |
| Earnings growth (this year) | +49.48% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -62.54% |
| P/E ratio | NM |
| Price/Sales | 9.05 |
| Price/Book | 3.21 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AWHAspira Women's Healt... | +0.13 | +2.17% |
| QTNTQuotient Ltd | +0.02 | +0.33% |
| OXFDOxford Immunotec Glo... | -0.02 | -0.09% |
| AXDXAccelerate Diagnosti... | +4.18 | +47.61% |
Data as of 4:23pm ET, 01/25/2021
Financials
| Next reporting date | March 11, 2021 |
| EPS forecast (this quarter) | -$0.37 |
| Annual revenue (last year) | $3.6M |
| Annual profit (last year) | -$50.9M |
| Net profit margin | -1,423.96% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Hampton, New Jersey |
Forecasts
